Last Updated:
Name Designation Appointment Date Status
Manju Jain

Appointed as Additional Director since September 2012

Additional Director 07-Sep-2012 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Rajesh Kumar Jain

Appointed as Director since May 2013

Director 24-May-2013 Current
Ramesh Chand Jain

Appointed as Director since May 2013

Director 24-May-2013 Current

People Timeline

Explore the timeline of key personnel in Shree Veer Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address T-170/1, Gali No. 4 Gautam Puri Shahdara, Delhi Delhi, 110053, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110053
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Shree Veer Pharmaceuticals Private Limited?
You can contact Shree Veer Pharmaceuticals Private Limited through their registered address at T-170/1, Gali No. 4 Gautam Puri Shahdara, Delhi Delhi, 110053, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Shree Veer Pharmaceuticals Private Limited?
The current directors of Shree Veer Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MANJU JAIN
  • RAJESH KUMAR JAIN
  • RAMESH CHAND JAIN
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available